Trump's tariffs will not only impact sponsors, but higher costs will ripple down the clinical trial supply chain in the US.

Aptar has a narrow economic moat, with durable switching costs in the Pharma business supported by intangible assets throughout the product portfolio from expertise in product regulation, design, and ...

Everyday painkillers, antibiotics, cancer medications, blood thinners and more are just some of the drugs that the U.S.

Ansell has moved to expand its manufacturing presence beyond China, to countries including India and Sri Lanka.

Sarom Packaging, a leading local and regional glass packaging manufacturer, has invested over EUR 3 million in launching a ...

Majority of leaders in life sciences -- pharmaceutical and medical technology companies -- and high-tech companies like ...

Vietnam’s pharmaceutical market is expected to have a year of optimism after experiencing a multicoloured gamut in 2024.

President Donald Trump on Saturday signed executive orders imposing sweeping tariffs on the country’s three largest trading ...

President Donald Trump's steep tariffs on Canada, Mexico and China could worsen exist­ing drug short­ages in the U.S. and ...

EUR/USD: ECB May Signal Further Accommodative Monetary Policy Ahead By Kelvin Wong - Dec 06, 2024 Pronounced weakness in manufacturing activities in Germany may spread to the broader Eurozone.

New Black Book Research survey reveals industry-wide concerns as tariffs on imports from Mexico, Canada, and China threaten ...